Literature DB >> 23300160

Combined effects of antenatal receipt of influenza vaccine by mothers and pneumococcal conjugate vaccine receipt by infants: results from a randomized, blinded, controlled trial.

Saad B Omer1, Khalequ Zaman, Eliza Roy, Shams E Arifeen, Rubhana Raqib, Laila Noory, Katherine Seib, Robert F Breiman, Mark C Steinhoff.   

Abstract

A 2 × 2 factorial trial was performed to determine the efficacy of antennal influenza vaccination of mothers plus pneumococcal conjugate vaccination of their infants against respiratory illness during early infancy. The efficacy of trivalent inactivated influenza vaccine (TIV; delivered to mothers) plus 7-valent pneumococcal vaccine (PCV7; delivered to infants) was higher than the efficacy of TIV alone or PCV7 alone. During the period of the study in which influenza was circulating, the efficacy of TIV plus PCV7 was 72.4% (95% confidence interval, 30.2%-89.1%) against febrile respiratory illness and 66.4% (95% CI, 14.3%-86.9%) against medically attended acute respiratory illness.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23300160     DOI: 10.1093/infdis/jit003

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Infants and the seasonal influenza vaccine. A global perspective on safety, effectiveness, and alternate forms of protection.

Authors:  Leah F Moriarty; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Maternal vaccination for the prevention of influenza: current status and hopes for the future.

Authors:  Varun K Phadke; Saad B Omer
Journal:  Expert Rev Vaccines       Date:  2016-04-22       Impact factor: 5.217

Review 3.  Pneumococcal vaccination during pregnancy for preventing infant infection.

Authors:  Surasith Chaithongwongwatthana; Waralak Yamasmit; Sompop Limpongsanurak; Pisake Lumbiganon; Jorge E Tolosa
Journal:  Cochrane Database Syst Rev       Date:  2015-01-23

4.  Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine.

Authors:  Adriana Weinberg; Petronella Muresan; Kelly M Richardson; Terence Fenton; Teresa Dominguez; Anthony Bloom; D Heather Watts; Mark J Abzug; Sharon A Nachman; Myron J Levin
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

5.  Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials.

Authors:  Saad B Omer; Dayna R Clark; Shabir A Madhi; Milagritos D Tapia; Marta C Nunes; Clare L Cutland; Eric A F Simões; Anushka R Aqil; Joanne Katz; James M Tielsch; Mark C Steinhoff; Niteen Wairagkar
Journal:  Lancet Respir Med       Date:  2020-06       Impact factor: 30.700

6.  Infant Pneumococcal Carriage During Influenza, RSV, and hMPV Respiratory Illness Within a Maternal Influenza Immunization Trial.

Authors:  Alastair F Murray; Janet A Englund; Jane Kuypers; James M Tielsch; Joanne Katz; Subarna K Khatry; Steven C Leclerq; Helen Y Chu
Journal:  J Infect Dis       Date:  2019-08-09       Impact factor: 5.226

Review 7.  Key considerations for successful implementation of maternal immunization programs in low and middle income countries.

Authors:  Sushena Krishnaswamy; Philipp Lambach; Michelle L Giles
Journal:  Hum Vaccin Immunother       Date:  2019-01-30       Impact factor: 3.452

8.  Effectiveness of pneumococcal conjugate vaccination against virus-associated lower respiratory tract infection among adults: a case-control study.

Authors:  Joseph A Lewnard; Katia J Bruxvoort; Vennis X Hong; Lindsay R Grant; Luis Jódar; Alejandro Cané; Bradford D Gessner; Sara Y Tartof
Journal:  J Infect Dis       Date:  2022-03-22       Impact factor: 7.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.